Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Yadamani S et al. | 2020 | - | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | - |
| Panjali Z et al. | 2022 | intact cell/cell culture, A549 (human lung cancer cell line) | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | - |
| Ramazi S et al. | 2023 | intact cell/cell culture, MCF-7 (human breast cancer cell line) and HFF cells (human foreskin fibroblast cells) | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | - |
| Amirinejad M et al. | 2024 | intact cell/cell culture, A172 and T98G (human glioblastoma cells) cell lines | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | - |
| Schimmelpfeng J | 1997 | intact cell/cell culture, HL-60 (human promyelocytic leukemia cells) | magnetic field, 50/60 Hz, co-exposure | 2 mT |
| Ansari RM et al. | 2000 | intact cell/cell culture, human-hamster hybrid cells | magnetic field, 50/60 Hz, co-exposure | 100 µT |
| Miyakoshi J et al. | 2000 | intact cell/cell culture, MO54 cells (derived from a human malignant glioma) | magnetic field, 50/60 Hz, co-exposure | 5–400 mT |
| Markkanen A et al. | 2001 | yeast (<i>Saccharomyces cerevisiae</i>/SEy2101a) | magnetic field, 50/60 Hz, co-exposure | 120 µT |
| Verheyen GR et al. | 2003 | intact cell/cell culture, human lymphocytes | magnetic field, 50/60 Hz, co-exposure | 80–800 µT |
| Kurian MV et al. | 2012 | intact cell/cell culture, H9c2 cells (myoblast from embryonal rat myocard) | magnetic field, 50/60 Hz, co-exposure | 1–240 µT |
| Esmekaya MA et al. | 2013 | bacterium, <i>Escherichia coli</i>/ATCC 25922 | magnetic field, 50/60 Hz, co-exposure | 2 mT |
| Luukkonen J et al. | 2014 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz, co-exposure | 100 µT |
| Jia HL et al. | 2014 | intact cell/cell culture, PC-12 cells (pheochromocytoma cell line from rat adrenal gland) | magnetic field, 50/60 Hz, co-exposure | 400 µT |
| Brisdelli F et al. | 2014 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, 50/60 Hz, co-exposure | 0.01–2 mT |
| de Groot MW et al. | 2014 | intact cell/cell culture, PC-12 cells (pheochromocytoma cell line from rat adrenal gland) | magnetic field, 50/60 Hz, co-exposure | 1–1,000 µT |
| Reale M et al. | 2014 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz, co-exposure | 1 mT |
| Kakikawa M et al. | 2014 | intact cell/cell culture, bacterium, <i>E. coli</i>/JE5595 | magnetic field, 50/60 Hz, co-exposure | 50 mT |
| Kakikawa M et al. | 2012 | bacterium, <i>Escherichia coli</i>/W3110 | magnetic field, 50/60 Hz, co-exposure | 5–50 mT |
| Giorgi G et al. | 2014 | intact cell/cell culture, human neuroblastoma cell line (BE(2)C) | magnetic field, 50/60 Hz, co-exposure | 1 mT |
| Grant DN et al. | 2015 | intact cell/cell culture, L929 cells (murine fibroblast cells) | magnetic field, 50/60 Hz, co-exposure | 1.2 mT |
| Benassi B et al. | 2016 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz, co-exposure | 1 mT |
| Baharara J et al. | 2016 | intact cell/cell culture, A2780 cells (cisplatin-resistant human ovarian adenocarcinoma cells) | magnetic field, 50/60 Hz, co-exposure | 20 mT |
| Nakayama M et al. | 2016 | intact cell/cell culture, macrophages (RAW 246) | magnetic field, 50/60 Hz, co-exposure | 500 µT |
| Yin C et al. | 2016 | intact cell/cell culture, primary hippocampal neurons from newborn Sprague-Dawley rats | magnetic field, 50/60 Hz, co-exposure | 8 mT |
| Sanie-Jahromi F et al. | 2016 | intact cell/cell culture, MCF-7 (human breast cancer cell line) and SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz, co-exposure | 0.25–0.5 mT |
| Sanie-Jahromi F et al. | 2017 | - | magnetic field, 50/60 Hz, co-exposure | - |
| Han Q et al. | 2018 | - | magnetic field, 50/60 Hz, co-exposure | - |
| Kakikawa M et al. | 2019 | - | magnetic field, 50/60 Hz, co-exposure | - |
| Özgün A et al. | 2018 | - | magnetic field, 50/60 Hz, co-exposure | - |
| Salek F et al. | 2021 | intact cell/cell culture | magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | 2.5 mT |
| Shibaki R et al. | 2022 | intact cell/cell culture, MES-SA and MES-SA/DxS cells (human uterine sarcoma cell lines) | magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | - |
| Nieminen V et al. | 2024 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | - |
| Koziorowska A et al. | 2017 | intact cell/cell culture, pig anterior pituitary gland cells | magnetic field, 50/60 Hz, low frequency | 2–6 mT |
| Xu A et al. | 2020 | - | magnetic field, 50/60 Hz, low frequency | - |
| Jedrzejczak-Silicka M et al. | 2021 | intact cell/cell culture, L929 cells (murine fibroblast cells) and HaCaT cells (human keratinocytes cell line) | magnetic field, 50/60 Hz, low frequency | 5.9–28.4 mT |
| Aparicio-Bautista DI et al. | 2022 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz, low frequency | - |
| Sendera A et al. | 2024 | intact cell/cell culture, human adipose-derived mesenchymal stem cells | magnetic field, 50/60 Hz, low frequency | - |
| Kayhan H et al. | 2020 | intact cell/cell culture, human, neonatal, healthy primary dermal fibroblast and MCF7 cells (human metastatic breast cancer cells) | magnetic field, 50/60 Hz, low frequency | - |
| Nurković J et al. | 2017 | - | magnetic field, 50/60 Hz, low frequency, also other exposures without EMF, co-exposure | - |
| Ciecholewska-Juśko D et al. | 2022 | bacterium, <i>Pseudomonas aeruginosa</i>, <i>Staphylococcus aureus</i> | magnetic field, 50/60 Hz, low frequency, also other exposures without EMF, co-exposure | - |
| Tang JY et al. | 2019 | - | magnetic field, 50/60 Hz, low frequency, signals/pulses | - |
| Gamble SC et al. | 1999 | intact cell/cell culture, SHD (syrian hamster dermal) cells | magnetic field, 50/60 Hz, power transmission line, co-exposure | 10–1,000 µT |
| Yaguchi H et al. | 2000 | intact cell/cell culture, mouse m5S cells | magnetic field, 50/60 Hz, power transmission line, co-exposure | 5–400 mT |
| Huang CY et al. | 2014 | intact cell/cell culture, HaCaT cells (human keratinocytes) partially transfected with CHK2 siRNA | magnetic field, 50/60 Hz, shielding/field deprivation | 1.5 mT |
| Mercado-Sáenz S et al. | 2019 | - | magnetic field, 50/60 Hz, signals/pulses | - |
| Master AM et al. | 2016 | - | magnetic field, 50/60 Hz, signals/pulses, co-exposure | - |
| Dehghani-Soltani S et al. | 2021 | intact cell/cell culture, A172 (human glioblastoma cells) and T98 cell line | magnetic field, 50/60 Hz, signals/pulses, co-exposure, also other exposures without EMF | 7 mT |
| Eremenko T et al. | 1997 | intact cell/cell culture, Friend erythroleukemia cell line (clone 745 A) | magnetic field, geomagnetic field, 50/60 Hz, shielding/field deprivation | 0.0025 nT–70 µT |
| Fojt L et al. | 2004 | bacterium, <i>Escherichia coli</i>, <i>Leclercia adecarboxylata</i>, <i>Staphylococcus aureus</i> | magnetic field, low frequency, 50/60 Hz | 2.7–10 mT |
| Del Re B et al. | 2004 | bacterium, <i>Escherichia coli</i>/Lac Z<sup>-</sup> strain (transformed with a plasmid containing a Tn10 derivative element expressing beta-galactosidase only after transposition)) | magnetic field, low frequency, 50/60 Hz | 0.05–1 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
